BasixSKY is the latest addition to Merit’s comprehensive inflation device portfolio, which includes both digital and analog devices. The basixSKY is available as a standalone solution and in kits with Merit Angioplasty Packs, configured to offer complementing AccessPLUS™, Honor®, and PhD™ hemostasis valves.
Designed with ease of use in mind, the new device is simple and highly responsive, creating an efficient approach to inflation. Rotational torque and handle revolutions to reach pressure are minimized, and a comfort-grip feature enables one-handed preparation.
Learn more about the basixSKY Inflation Device.
Endovascular interventions, such as balloon angioplasty and stent placement procedures used to widen narrowed or blocked coronary and peripheral arteries, utilize an inflation device. These are minimally invasive techniques that can restore blood flow through diseased vessels and minimize damage to surrounding tissue. In 2024, it is estimated that 1.79 million coronary balloon and stent placement procedures will be performed in
“We are pleased to broaden our portfolio of inflation devices,” said
ABOUT MERIT MEDICAL Founded in 1987,
TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release are the property of
CONTACTS
PR/Media Inquiries
Sarah Comstock
Merit Medical
+1-801-432-2864 | sarah.comstock@merit.com
INVESTOR INQUIRIES
Westwicke - ICR
+1-443-213-0509 | mike.piccinino@westwicke.com
1. Clarivate DRG, Market Insights ǀ Interventional Cardiology Devices ǀ
![](https://ml.globenewswire.com/media/NGFkNDI4NzUtMTdlNC00MzkzLWFiMTgtMjQyYzNhYzY0ZmYwLTEwMjAxMDk=/tiny/Merit-Medical-Systems-Inc-.png)
2024 GlobeNewswire, Inc., source